A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": [
"https://www.w3.org/ns/activitystreams",
{
"ostatus": "http://ostatus.org#",
"atomUri": "ostatus:atomUri",
"inReplyToAtomUri": "ostatus:inReplyToAtomUri",
"conversation": "ostatus:conversation",
"sensitive": "as:sensitive",
"toot": "http://joinmastodon.org/ns#",
"votersCount": "toot:votersCount",
"blurhash": "toot:blurhash",
"focalPoint": {
"@container": "@list",
"@id": "toot:focalPoint"
},
"Hashtag": "as:Hashtag"
}
],
"id": "https://pubeurope.com/users/europesays/statuses/114574232970779435",
"type": "Note",
"summary": null,
"inReplyTo": null,
"published": "2025-05-26T12:54:12Z",
"url": "https://pubeurope.com/@europesays/114574232970779435",
"attributedTo": "https://pubeurope.com/users/europesays",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://pubeurope.com/users/europesays/followers"
],
"sensitive": false,
"atomUri": "https://pubeurope.com/users/europesays/statuses/114574232970779435",
"inReplyToAtomUri": null,
"conversation": "tag:pubeurope.com,2025-05-26:objectId=2834518:objectType=Conversation",
"content": "<p><a href=\"https://www.europesays.com/2110103/\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://www.</span><span class=\"\">europesays.com/2110103/</span><span class=\"invisible\"></span></a> Australia Delivers Certainty for US Biotechs in 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&D Rebates #2025: Avance <a href=\"https://pubeurope.com/tags/And\" class=\"mention hashtag\" rel=\"tag\">#<span>And</span></a> <a href=\"https://pubeurope.com/tags/australia\" class=\"mention hashtag\" rel=\"tag\">#<span>australia</span></a> <a href=\"https://pubeurope.com/tags/Biotechs\" class=\"mention hashtag\" rel=\"tag\">#<span>Biotechs</span></a> <a href=\"https://pubeurope.com/tags/Certainty\" class=\"mention hashtag\" rel=\"tag\">#<span>Certainty</span></a> <a href=\"https://pubeurope.com/tags/Clinical\" class=\"mention hashtag\" rel=\"tag\">#<span>Clinical</span></a> <a href=\"https://pubeurope.com/tags/delivers\" class=\"mention hashtag\" rel=\"tag\">#<span>delivers</span></a> <a href=\"https://pubeurope.com/tags/FAST\" class=\"mention hashtag\" rel=\"tag\">#<span>FAST</span></a> <a href=\"https://pubeurope.com/tags/for\" class=\"mention hashtag\" rel=\"tag\">#<span>for</span></a> <a href=\"https://pubeurope.com/tags/in\" class=\"mention hashtag\" rel=\"tag\">#<span>in</span></a> <a href=\"https://pubeurope.com/tags/Offers\" class=\"mention hashtag\" rel=\"tag\">#<span>Offers</span></a> <a href=\"https://pubeurope.com/tags/Predictability\" class=\"mention hashtag\" rel=\"tag\">#<span>Predictability</span></a> <a href=\"https://pubeurope.com/tags/r\" class=\"mention hashtag\" rel=\"tag\">#<span>r</span></a>&d <a href=\"https://pubeurope.com/tags/Rebates\" class=\"mention hashtag\" rel=\"tag\">#<span>Rebates</span></a> <a href=\"https://pubeurope.com/tags/regulatory\" class=\"mention hashtag\" rel=\"tag\">#<span>regulatory</span></a> <a href=\"https://pubeurope.com/tags/StartUp\" class=\"mention hashtag\" rel=\"tag\">#<span>StartUp</span></a> <a href=\"https://pubeurope.com/tags/US\" class=\"mention hashtag\" rel=\"tag\">#<span>US</span></a></p>",
"contentMap": {
"en": "<p><a href=\"https://www.europesays.com/2110103/\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://www.</span><span class=\"\">europesays.com/2110103/</span><span class=\"invisible\"></span></a> Australia Delivers Certainty for US Biotechs in 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&D Rebates #2025: Avance <a href=\"https://pubeurope.com/tags/And\" class=\"mention hashtag\" rel=\"tag\">#<span>And</span></a> <a href=\"https://pubeurope.com/tags/australia\" class=\"mention hashtag\" rel=\"tag\">#<span>australia</span></a> <a href=\"https://pubeurope.com/tags/Biotechs\" class=\"mention hashtag\" rel=\"tag\">#<span>Biotechs</span></a> <a href=\"https://pubeurope.com/tags/Certainty\" class=\"mention hashtag\" rel=\"tag\">#<span>Certainty</span></a> <a href=\"https://pubeurope.com/tags/Clinical\" class=\"mention hashtag\" rel=\"tag\">#<span>Clinical</span></a> <a href=\"https://pubeurope.com/tags/delivers\" class=\"mention hashtag\" rel=\"tag\">#<span>delivers</span></a> <a href=\"https://pubeurope.com/tags/FAST\" class=\"mention hashtag\" rel=\"tag\">#<span>FAST</span></a> <a href=\"https://pubeurope.com/tags/for\" class=\"mention hashtag\" rel=\"tag\">#<span>for</span></a> <a href=\"https://pubeurope.com/tags/in\" class=\"mention hashtag\" rel=\"tag\">#<span>in</span></a> <a href=\"https://pubeurope.com/tags/Offers\" class=\"mention hashtag\" rel=\"tag\">#<span>Offers</span></a> <a href=\"https://pubeurope.com/tags/Predictability\" class=\"mention hashtag\" rel=\"tag\">#<span>Predictability</span></a> <a href=\"https://pubeurope.com/tags/r\" class=\"mention hashtag\" rel=\"tag\">#<span>r</span></a>&d <a href=\"https://pubeurope.com/tags/Rebates\" class=\"mention hashtag\" rel=\"tag\">#<span>Rebates</span></a> <a href=\"https://pubeurope.com/tags/regulatory\" class=\"mention hashtag\" rel=\"tag\">#<span>regulatory</span></a> <a href=\"https://pubeurope.com/tags/StartUp\" class=\"mention hashtag\" rel=\"tag\">#<span>StartUp</span></a> <a href=\"https://pubeurope.com/tags/US\" class=\"mention hashtag\" rel=\"tag\">#<span>US</span></a></p>"
},
"attachment": [
{
"type": "Document",
"mediaType": "image/jpeg",
"url": "https://media.pubeurope.com/media_attachments/files/114/574/232/951/135/092/original/9698f850616055b9.jpg",
"name": "Australia Delivers Certainty for US Biotechs in 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&D Rebates",
"blurhash": "UMRpIGR:~Tt4tSs+-jWYRkR.M|jY?EobRoa~",
"width": 1200,
"height": 644
}
],
"tag": [
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/and",
"name": "#and"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/australia",
"name": "#australia"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/biotechs",
"name": "#biotechs"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/certainty",
"name": "#certainty"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/clinical",
"name": "#clinical"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/delivers",
"name": "#delivers"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/fast",
"name": "#fast"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/for",
"name": "#for"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/in",
"name": "#in"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/offers",
"name": "#offers"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/predictability",
"name": "#predictability"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/r",
"name": "#r"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/rebates",
"name": "#rebates"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/regulatory",
"name": "#regulatory"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/startup",
"name": "#startup"
},
{
"type": "Hashtag",
"href": "https://pubeurope.com/tags/us",
"name": "#us"
}
],
"replies": {
"id": "https://pubeurope.com/users/europesays/statuses/114574232970779435/replies",
"type": "Collection",
"first": {
"type": "CollectionPage",
"next": "https://pubeurope.com/users/europesays/statuses/114574232970779435/replies?only_other_accounts=true&page=true",
"partOf": "https://pubeurope.com/users/europesays/statuses/114574232970779435/replies",
"items": []
}
},
"likes": {
"id": "https://pubeurope.com/users/europesays/statuses/114574232970779435/likes",
"type": "Collection",
"totalItems": 0
},
"shares": {
"id": "https://pubeurope.com/users/europesays/statuses/114574232970779435/shares",
"type": "Collection",
"totalItems": 0
}
}